公开(公告)号：US5705469A

公开(公告)日：1998-01-06

申请号：US428158

申请日：1995-04-20

申请人： Alan David Blake ,  Jozef Philemona R. Geudens ,  Paul Andrew Hardy ,  Fabrice Francois J. Questel

发明人： Alan David Blake ,  Jozef Philemona R. Geudens ,  Paul Andrew Hardy ,  Fabrice Francois J. Questel

IPC分类号： C11D3/00 ,  C11D3/386 ,  C11D3/02

CPC分类号： C11D3/38663 ,  C11D3/0042

摘要： A process is disclosed for the manufacture of a liquid detergent composition comprising a sulphiting agent and an enzyme system. Said enzyme system and said sulphiting agent interact together so as to generate odors which result in an odor deviation in said detergent composition. In the process of the invention, said enzyme system and said sulphiting agent are intimately mixed together separately from the remainder of the detergent composition so as to generate said odors outside the remainder of said detergent composition. Also disclosed is an enzyme premix consisting essentially of said enzyme system and said sulphiting agent.

摘要翻译： PCT No.PCT / US93 / 09390 371日期1995年04月20日 102（e）日期1995年4月20日PCT提交1993年10月1日PCT公布。 公开号WO94 / 10283 日期1994年5月11日公开了制备包含亚硫酸盐剂和酶体系的液体洗涤剂组合物的方法。 所述酶系统和所述亚硫酸化剂相互作用，以产生在所述洗涤剂组合物中导致气味偏差的气味。 在本发明的方法中，所述酶体系和所述亚硫酸盐剂与洗涤剂组合物的其余部分分开紧密地混合在一起，以便在所述洗涤剂组合物的其余部分之外产生所述气味。 还公开了基本上由所述酶系和所述亚硫酸化剂组成的酶预混物。

公开(公告)号：US5648329A

公开(公告)日：1997-07-15

申请号：US608222

申请日：1996-02-28

申请人： Alan David Blake ,  Jean-Pol Boutique ,  Jozef Philomena Geudens ,  Patrick Firmin Delplancke

发明人： Alan David Blake ,  Jean-Pol Boutique ,  Jozef Philomena Geudens ,  Patrick Firmin Delplancke

IPC分类号： C11D1/52 ,  C11D3/02 ,  C11D3/04 ,  C11D3/20 ,  C11D3/32 ,  C11D3/33 ,  C11D11/00 ,  C11D17/00

CPC分类号： C11D3/046 ,  C11D1/525 ,  C11D17/0004 ,  C11D3/042 ,  C11D3/2044 ,  C11D3/32

摘要： A liquid premix for use in a detergent composition which comprises at least 40% by weight of polyhydroxy fatty acid amide and an effective amount of borate-containing material to prevent crystalization and/or precipitation of the liquid premix when stored for at least 2 weeks at 20 .degree. C., and methods of making same.

摘要翻译： PCT No.PCT / US93 / 09578 371日期：1995年4月7日 102（e）1995年4月7日PCT PCT 1993年10月8日PCT公布。 出版物WO92 / 06154 日期1992年4月16日一种用于洗涤剂组合物的液体预混物，其包含至少40重量％的多羟基脂肪酸酰胺和有效量的含硼酸盐材料，以防止液体预混物存储时的结晶和/或沉淀， 在20℃下至少2周，以及制备方法。

公开(公告)号：US4098905A

公开(公告)日：1978-07-04

申请号：US715074

申请日：1976-08-17

申请人： David Blake ,  Louis Ferstandig

发明人： David Blake ,  Louis Ferstandig

IPC分类号： A61K31/045 ,  A61K31/06 ,  A61K31/13 ,  A61K31/185 ,  C07C31/38

CPC分类号： A61K31/185 ,  A61K31/045 ,  A61K31/06 ,  A61K31/13 ,  C07C31/38

摘要： The ability of a male to impregnate a female is reversibly effected by administering to the male, preferably daily in pill form, an effective amount of a trihalomethyl-containing lower alkanol, aldehyde, acid, amine, ether, or the like, or a derivative such as an amide or salt which liberates such compound in the body. The length of time needed for the male to regain his fertility depends upon the dosage of active material, preferably trifluoroethanol.

公开(公告)号：US20230122299A1

公开(公告)日：2023-04-20

申请号：US17969547

申请日：2022-10-19

申请人： David Blake

发明人： David Blake

IPC分类号： A44C27/00 ,  A44C17/00

摘要： What is provided are commemorative pieces of jewelry that include food, beverage, and/or botanical extracts and methods of making the same. An embodiment of a piece of jewelry comprises a mixture including one or more first layers of cured resin and an extract, wherein the mixture is inlaid in the piece of jewelry, and wherein the extract is derived from a food, an alcoholic beverage, a non-alcoholic beverage, a plant or a botanical. The piece of jewelry further comprises one or more second layers of cured resin.

公开(公告)号：US20130091575A1

公开(公告)日：2013-04-11

申请号：US13269463

申请日：2011-10-07

申请人： David Paul Duncan ,  David Blake Farmer

发明人： David Paul Duncan ,  David Blake Farmer

IPC分类号： G06F12/14 ,  G06F21/00

CPC分类号： G06F21/56 ,  G06F21/567

摘要： A removable media device, which may be a USB attached device or other type of removable media device, includes a software program located on the device which upon startup or access, the software program scans one or more of electronic files stored on the removable media device and electronic files being transferred to or from the electronic media device and to or from a host computing system for the detection of viruses therein. The software program is further configured to block the transfer of detected virus-containing electronic files and to disallow the copy or writing of files to or from the removable media device to or from a host computing system that can not be scanned. The software program is further configured to block the encryption of files being written to a removable media device if such device contains hardware or software encryption if such files can not be scanned.

摘要翻译： 可移动介质设备（其可以是USB连接设备或其他类型的可移动介质设备）包括位于设备上的软件程序，其在启动或访问时，软件程序扫描存储在可移动介质设备上的一个或多个电子文件 以及电子文件被传送到或从电子媒体设备传送到主计算系统或从主计算系统传送到主计算系统以用于检测其中的病毒。 软件程序还被配置为阻止检测到的含有病毒的电子文件的传送，并且不允许将文件复制或写入到可移动介质设备到或不能扫描主机计算系统的文件。 该软件程序还被配置为如果这样的设备包含硬件或软件加密（如果这样的文件不能被扫描），则阻止正在写入可移动媒体设备的文件的加密。

公开(公告)号：US20110267765A1

公开(公告)日：2011-11-03

申请号：US13100071

申请日：2011-05-03

申请人： Greg Fuchs ,  Gale Nordling ,  George Anderson ,  David Blake Jackson

发明人： Greg Fuchs ,  Gale Nordling ,  George Anderson ,  David Blake Jackson

IPC分类号： G06F1/16

CPC分类号： G06F1/1656 ,  G06F1/182

摘要： Electromagnetically shielded portable storage devices are disclosed. One such device includes an electromagnetically shielded enclosure having an interior volume, the electromagnetically shielded enclosure including a plurality of shielded walls and sized to be manually carried by a person. The interior volume of the enclosure is isolated from high-frequency electromagnetic energy generated external to the enclosure. The device includes at least one storage device positioned within the interior volume, and at least one communicative connection extending from the at least one storage device to a communicative socket accessible external to the electromagnetically shielded enclosure. The at least one communicative connection is configured to allow access to the storage device by a computing system external to the electromagnetically shielded enclosure. The device also includes an electrical filter positioned at least partially within the electromagnetically shielded enclosure, and including a low-pass filter selected to prevent spurious or intentional conductive high-frequency electromagnetic energy from entering the interior volume via the communicative connection.

摘要翻译： 公开了电磁屏蔽便携式存储装置。 一种这样的装置包括具有内部体积的电磁屏蔽的外壳，电磁屏蔽的外壳包括多个屏蔽壁，其尺寸被人手动承载。 外壳的内部体积与外壳外部产生的高频电磁能隔绝。 所述装置包括位于所述内部容积内的至少一个存储装置，以及从所述至少一个存储装置延伸到在所述电磁屏蔽外壳外部可访问的通信插座的至少一个通信连接。 所述至少一个通信连接被配置为允许通过所述电磁屏蔽外壳外部的计算系统访问所述存储设备。 该装置还包括至少部分地位于电磁屏蔽的外壳内的电过滤器，并且包括选择的低通滤波器，以防止假的或有意的导电高频电磁能量经由通信连接进入内部体积。

公开(公告)号：US08027992B2

公开(公告)日：2011-09-27

申请号：US12055545

申请日：2008-03-26

申请人： David Blake ,  Michelle Eddie

发明人： David Blake ,  Michelle Eddie

IPC分类号： G06F17/30 ,  G06F7/00

CPC分类号： G06F8/61 ,  Y10S707/966

摘要： A system and method for managing and verifying the installation of software on a modular information handling system includes a bar file database and an installation management module. The bar file database stores bar files. The bar files each are related to a component of a modular information handling system. The installation management module is able to receive a bar file and communicate with the bar file database to identify and access each bar file associated with the modular information handling system.

摘要翻译： 用于管理和验证在模块化信息处理系统上安装软件的系统和方法包括条形文件数据库和安装管理模块。 条形文件数据库存储条形文件。 每个条形码文件都与模块化信息处理系统的组件相关。 安装管理模块能够接收条形文件并与条形文件数据库进行通信，以识别和访问与模块化信息处理系统相关联的每个条形文件。

公开(公告)号：US07902361B2

公开(公告)日：2011-03-08

申请号：US11408463

申请日：2006-04-21

申请人： Shudong Wang ,  Gavin Wood ,  Kenneth Duncan ,  Christopher Meades ,  Darren Gibson ,  Janice McLachlan ,  Alex Perry ,  David Blake ,  Daniella I. Zheleva ,  Peter Martin Fischer

发明人： Shudong Wang ,  Gavin Wood ,  Kenneth Duncan ,  Christopher Meades ,  Darren Gibson ,  Janice McLachlan ,  Alex Perry ,  David Blake ,  Daniella I. Zheleva ,  Peter Martin Fischer

IPC分类号： C07D403/04 ,  C07D403/14 ,  C07D417/04 ,  C07D417/14 ,  A61K31/506 ,  A61P3/10 ,  A61P19/02 ,  A61P35/02

CPC分类号： C07D417/04 ,  C07D417/14

摘要： The present invention relates to compounds of formula I, or pharmaceutically acceptable salts thereof, wherein R1 and R5 are each independently H, C(ORj′) or a hydrocarbyl group optionally substituted by one or more R6 groups; R2, R3, and R4 are each independently H, alkyl or alkenyl, each of which may be optionally substituted with one or more R7 groups; R6 and R7 are each independently halogen, NO2, CN, (CH2)mORa, O(CH2)nORb, (CH2)pNRcRd, CF3, COORe, CONRfRg, CORh, SO3H, SO2Ri, SO2NRjRk, (CH2)qNRa′CORg′, Rf′, (CH2)rNRb′SO2Rh′, SO2NRd′Ri′, SO2NRe′(CH2)sORc′, heterocycloalkyl or heteroaryl, wherein said heterocycloalkyl and heteroaryl may be optionally substituted by one or more substituents selected from aralkyl, sulfonyl, Rm and CORn; Rg′, Rh′, Ri′ and Rj′ are each independently selected from alkyl, aryl, aralkyl and heteroaryl, each of which may be optionally substituted with one or more substituents selected from halogen, OH, NO2, NH2 CF3 and COOH; m, p, q and r are each independently 0, 1, 2 or 3; n and s are each independently 1, 2, or 3; and Ra-n and Ra′-f′ are each independently H or alkyl. Further aspects of the invention relate to pharmaceutical compositions comprising such compounds, and their use in the preparation of a medicament for treating one or more of the following: a proliferative disorder, a viral disorder, a CNS disorder, a stroke, alopecia and diabetes.

摘要翻译： 本发明涉及式I化合物或其药学上可接受的盐，其中R 1和R 5各自独立地为H，C（OR j'）或任选被一个或多个R 6基团取代的烃基; R 2，R 3和R 4各自独立地为H，烷基或烯基，其各自可以任选被一个或多个R 7基团取代; R6和R7各自独立地为卤素，NO2，CN，（CH2）mORa，O（CH2）nORb，（CH2）pNRcRd，CF3，COORe，CONRfRg，CORh，SO3H，SO2Ri，SO2NRjRk，（CH2）qNRa'CORg' Rf'，（CH2）rNRb'SO2Rh'，SO2NRd'Ri'，SO2NRe'（CH2）sORc'，杂环烷基或杂芳基，其中所述杂环烷基和杂芳基可以任选地被一个或多个选自芳烷基，磺酰基，R m和 玉米; R''，R''，R''和R“'各自独立地选自烷基，芳基，芳烷基和杂芳基，它们各自可以被一个或多个选自卤素，OH，NO 2，NH 2 CF 3和COOH的取代基取代; m，p，q和r各自独立地为0,1,2或3; n和s各自独立地为1,2或3; 和Ra-n和Ra'-f'各自独立地为H或烷基。 本发明的其它方面涉及包含这些化合物的药物组合物及其在制备用于治疗以下一种或多种的药物中的用途：增殖性病症，病毒病症，CNS病症，中风，脱发和糖尿病。

公开(公告)号：US07317760B2

公开(公告)日：2008-01-08

申请号：US10716957

申请日：2003-11-19

申请人： Gibong Jeong ,  David Blake Woodall

发明人： Gibong Jeong ,  David Blake Woodall

IPC分类号： H04L27/28

CPC分类号： H04B1/7117 ,  H04B1/7113

摘要： System and method for managing finger and path resources. A preferred embodiment comprises receiving a delay profile, processing paths from the delay profile, placing the processed paths into a plurality of sets based on path criteria, and assigning the placed processed paths to demodulating fingers. A preferred embodiment further comprises the use of historical information on paths in the placing.

摘要翻译： 用于管理手指和路径资源的系统和方法。 优选实施例包括接收延迟分布，根据延迟分布处理路径，基于路径准则将经处理的路径放置成多个集合，以及将所处理的路径分配给解调手指。 优选实施例还包括在放置中的路径上使用历史信息。

公开(公告)号：US20070021452A1

公开(公告)日：2007-01-25

申请号：US11408463

申请日：2006-04-21

申请人： Shudong Wang ,  Gavin Wood ,  Kenneth Duncan ,  Christopher Meades ,  Darren Gibson ,  Janice McLachlan ,  Alex Perry ,  David Blake ,  Daniella Zheleva ,  Peter Fischer

发明人： Shudong Wang ,  Gavin Wood ,  Kenneth Duncan ,  Christopher Meades ,  Darren Gibson ,  Janice McLachlan ,  Alex Perry ,  David Blake ,  Daniella Zheleva ,  Peter Fischer

IPC分类号： A61K31/506 ,  C07D417/04

CPC分类号： C07D417/04 ,  C07D417/14

摘要： The present invention relates to compounds of formula I, or pharmaceutically acceptable salts thereof, wherein R1 and R5 are each independently H, C(ORj′) or a hydrocarbyl group optionally substituted by one or more R6 groups; R2, R3, and R4 are each independently H, alkyl or alkenyl, each of which may be optionally substituted with one or more R7 groups; R6 and R7 are each independently halogen, NO2, CN, (CH2)mORa, O(CH2)nORb, (CH2)pNRcRd, CF3, COORe, CONRfRg, CORh, SO3H, SO2Ri, SO2NRjRk, (CH2)qNRa′CORg′, Rf′, (CH2)rNRb′SO2Rh′, SO2NRd′Ri′, SO2NRe′(CH2)sORc′, heterocycloalkyl or heteroaryl, wherein said heterocycloalkyl and heteroaryl may be optionally substituted by one or more substituents selected from aralkyl, sulfonyl, Rm and CORn; Rg′, Rh′, Ri′ and Rj′ are each independently selected from alkyl, aryl, aralkyl and heteroaryl, each of which may be optionally substituted with one or more substituents selected from halogen, OH, NO2, NH2 CF3 and COOH; m, p, q and r are each independently 0, 1, 2 or 3; n and s are each independently 1, 2, or 3; and Ra-n and Ra′-f′ are each independently H or alkyl. Further aspects of the invention relate to pharmaceutical compositions comprising such compounds, and their use in the preparation of a medicament for treating one or more of the following: a proliferative disorder, a viral disorder, a CNS disorder, a stroke, alopecia and diabetes.